I think the patent office will want more data to see that it works for the specific uses, so I don't think the overall patent will be approved as is. Ultimately, I think they will have to break it down as they get clinical trial data that proves it works for a specific disease condition. So, for example, once the clinical trial data comes out on thyroiditis, I think they could get approval on that, but I'm not sure what the process would be or how long it would take.
However, keep in mind, they have a product on the market that works and that people will buy once the news is out. It will be the hot topic of conversation on every medical talk show. If a copy cat manufacturer tries to sell anatabine they would have a variety of hurdles to jump including lawsuits from Star. IMHO, any copycat manufacturer would get killed in court and face treble damage for willful infringement.
JMHO,
NJ
News 
Market Data 
Discover 
